Publication | Closed Access

In vivo efficacy of dendrimer–methylprednisolone conjugate formulation for the treatment of lung inflammation

InflammationAnti-inflammatoryInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationMedicineDendrimer–methylprednisolone Conjugate FormulationPulmonary PharmacologyVivo EfficacyPulmonary MedicinePharmacotherapyPharmacologyPulmonary Disease